NCT06258044

Brief Summary

This retrospective study focuses on benign and malignant classification of thyroid nodules using deep learning techniques and evaluates the value of deep learning based nomograms in the classification of TI-RADS category 4 thyroid nodules to improve the accuracy of benign and malignant identification of TI-RADS category 4 thyroid nodules. Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 4, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
Last Updated

February 14, 2024

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

January 4, 2024

Last Update Submit

February 5, 2024

Conditions

Keywords

TI-RADS category 4 thyroid nodulesYOLOv3 modelnomograms

Outcome Measures

Primary Outcomes (4)

  • deep learning prediction model(YOLOv3) and the model evaluation

    Based on the characteristics of benign and malignant thyroid nodules, the dataset was divided into a training set and a test set using the cross-validation method, and the YOLOv3 model was trained using data from the training set, and the performance of the model was evaluated using data from the test set.The model is evaluated using a number of metrics such as: precision-recall curve, effective classification precision, confusion matrix and area under the curve.

    Immediately evaluated after the prediction model was built

  • nomogram prediction and assessment

    Factoring clinical features, ultrasound grading and model predictions to map nomograms using R language.Evaluation of the nomogram using various metrics, including subject operating characteristic curves, calibration curves and decision curve analysis

    Immediately evaluated after the nomogram was built

  • Selection of clinical features and assessment

    The researchers selected patients with TI-RADS category 4 thyroid nodules within 1 year to comprise the dataset. The researchers analyzed the clinical factors in the dataset and analyzed the significance of these clinical factors on the statistical results and clinical characteristics using the Wilcoxon two-sample rank sum test or chi-square test.

    After the dataset is collected and pathology results are obtained, the statistical results obtained are analyzed for clinical factors, averaging about 1 year.

  • Impact and assessment of ultrasound grading

    The researchers selected patients with TI-RADS category 4 thyroid nodules within 1 year to comprise the dataset. The researchers analyzed the results of grading TI-RADS category 4 nodules in this dataset and determined the significance of ultrasound grading on the statistical results using the chi-square test.

    The graded results of the ultrasound examination were analyzed after the data set collection was completed, the ultrasound examination was completed and the final pathology results were obtained, on average about 1 year.

Study Arms (2)

maligant

Thyroid nodules with surgical or puncture biopsy-confirmed pathological findings of malignancy in the TI-RADS4 category

benign

Thyroid nodules with surgical or puncture biopsy-confirmed pathological findings of benign TI-RADS4 category

Eligibility Criteria

Age23 Years - 78 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study collected data on a total of 500 TI-RADS category 4 thyroid nodules from 500 patients who attended the First Affiliated Hospital of Shandong First Medical University from April 2022 to November 2023.

You may qualify if:

  • Ultrasound-confirmed diagnosis of thyroid nodules that are classified as TI-RADS category 4.
  • Availability of pathological results.

You may not qualify if:

  • Lack of pathological diagnosis.
  • History of thyroid surgery or other treatments.
  • Poor quality of ultrasound images of thyroid nodules.
  • Incomplete clinical and imaging data of the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

QianfoshanH

Jinan, Shandong, China

Location

MeSH Terms

Conditions

Thyroid Nodule

Condition Hierarchy (Ancestors)

Thyroid NeoplasmsEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of Ultrasound

Study Record Dates

First Submitted

January 4, 2024

First Posted

February 14, 2024

Study Start

April 1, 2022

Primary Completion

November 30, 2023

Study Completion

November 30, 2023

Last Updated

February 14, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations